Treatment of central nervous system infections in small animals.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy / Q000662:veterinary; D001812:Blood-Brain Barrier / Q000187:drug effects; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000662:veterinary*; D003453:Cryptococcosis / Q000188:drug therapy / Q000662:veterinary; D004216:Distemper / Q000628:therapy; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000188:drug therapy / Q000662:veterinary; D007239:Infections / Q000188:drug therapy / Q000662:veterinary*; D008581:Meningitis / Q000188:drug therapy / Q000662:veterinary; D011818:Rabies / Q000628:therapy / Q000662:veterinary; D014124:Toxoplasmosis, Animal / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004338:Drug Combinations